About Hero

Latest news

OGT launches SureSeq Myeloid Plus panel and Universal NGS Complete Workflow

05 Oct 2022

Enhanced NGS portfolio includes Interpret Software updates and enables rapid and confident variant detection even in difficult-to-sequence regions.

Read article
OGT launches SureSeq Myeloid Plus panel and Universal NGS Complete Workflow Featured Image

Upcoming event

European Hematology Association (EHA) 2023 Congress

  • Date: 08 Jun 2023
  • Location: Frankfurt, Germany
Learn more
CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter

  • Filter by
Myeloid Plus And ULPK Launch PR

OGT launches SureSeq Myeloid Plus panel and Universal NGS Complete Workflow

05 Oct 2022

Enhanced NGS portfolio includes Interpret Software updates and enables rapid and confident variant detection even in difficult-to-sequence regions.

Read
Global Reach

OGT significantly expands global reach

12 Jul 2022

Expansion of access to clinical support network and market-leading genomic solutions aims to improve patient outcomes.

Read
Adrian Smith CEO PR

OGT welcomes Adrian Smith as CEO

04 Apr 2022

New leadership will drive OGT’s mission to improve clinical care by partnering with customers.

Read
Cytocell Uni V2

OGT expands latest support and training initiative with CytoCell University

04 Aug 2021

CytoCell University offers extensive FISH expertise and reaffirms commitment to customer support and training.

Read
OGT Brand Launch

OGT pledges partnership with significant brand refresh and integration

24 Mar 2021

New integrated website, expanded resources and substantial worldwide support reaffirm partnership and commitment to customers.

Read
NGS Scientist Looking At Slide

OGT's NGS panels to be featured in user workshop at AMP 2020

09 Nov 2020

In the workshop users will explain how OGT’s SureSeq™ NGS panels can increase throughput and save time and cost in the detection of a wide variety of aberrations.

Read
Cancer Cell

OGT expands NGS cancer panel offering

03 Nov 2020

Launch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders.

Read
Array Scientist Loads Sample

NHS study confirms higher reporting rate for OGT's CytoSure v3 array

22 Jul 2020

Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design.

Read
Global Reach

OGT's CytoCell portfolio available via Sysmex in China and Spain

06 Jul 2020

Addition of direct-sales territories follows successes across Europe and APAC and provides customers with enhanced local sales and support services.

Read
Scientist Inspecting Slide

OGT delivers translocation and partial tandem duplication detection

07 Apr 2020

New content and Interpret NGS analysis software detection capabilities include BCR-ABL and KMT2A-PTD detection.

Read
COVID 19 News

OGT’s response during the COVID-19 outbreak

23 Mar 2020

During these unprecedented times, OGT remains committed and ready to support you...

Read
Eye

Sysmex and the Kobe City Eye Hospital sign collaboration agreement

05 Mar 2020

Reinforcing collaboration toward the realization of genomic medicine in the area of ophthalmic disorders.

Read
{{blogDetailsPage.ListingImageAltTag}}

{{blogDetailsPage.Title}}

{{blogDetailsPage.FriendlyDate}}

{{blogDetailsPage.Summary}}

Read
Sorry there are no articles matching your search.
Show more